The Impact of Lymph Node Number on Survival in Patients With Lymph Node-Negative Pancreatic Cancer

Authors:
  • CSCan-Lan Sun
    Can-Lan Sun
  • AAAvo Artinyan
    Avo Artinyan
  • PMPablo Mojica-Manosa
    Pablo Mojica-Manosa
  • SBSmita Bhatia
    Smita Bhatia
  • JEJoshua DI Ellenhorn
    Joshua DI Ellenhorn
  • JKJoseph Kim
    Joseph Kim

Abstract
The role of lymph node (LN) dissection for pancreatic cancer remains uncertain, and guidelines for a minimum LN number have not been established. We hypothesized that LN number in node-negative (N0) pancreatic cancer influences survival. The Surveillance, Epidemiology, and End Results database was queried for patients undergoing resection for N0 pancreatic adenocarcinoma between 1988 and 2003. Lymph node number was categorized as 1-10, 11-20, and >20. In a cohort of 1915 patients, the median LN number was 7 (range 1-57); 1365 (71%) patients had 20 groups (median, 20 vs 23 months, respectively, P = 0.14). Multivariate analysis demonstrated the prognostic significance of LN number for determining overall survival (hazard ratio 0.98, 95% confidence interval: 0.97-0.99; P10 LN is associated with improved survival in N0 disease and should be considered a benchmark for adequacy of surgery and/or pathology. Currently, only a minority of patients are assessed by this measure. The variation in LN number may be indicative of diverse surgical technique and/or pathologic analysis and warrants further investigation.

This publication has 41 references indexed in Scilit: